Liver Cancer Information Center
Knowledge is power. Are you facing a new diagnosis, recurrence, living with metastatic disease, or supporting a loved one through their cancer journey? The Cancer Connect Liver Cancer Information Center has current, evidence-based information for you. Get the facts about liver cancer prevention, early detection, treatment, and survivorship, and stay up to date with ongoing liver cancer research that could impact your treatment decisions through our daily cancer news.
You are not alone—join us in our safe and private online community for support and inspiration, and share your experience with thousands of other individuals who have been affected by liver cancer. Join the discussion now to share your story and to learn how others like you have dealt with diagnosis, treatment decisions, side effects, living with metastatic disease, caregiving, and survivorship. Login or register here.
People who follow the diet and lifestyle recommendations laid out by the WCRF and the AICR have a 20 percent reduced risk of dying from cancer. Statins Linked to Lower Risk of Liver Cancer in Hepatitis C
People infected with chronic hepatitis C are less likely to develop liver cancer if they are taking statins. Cancer Deaths on the Decline
Overall cancer death rates are declining and cancer incidence has decreased in men and stabilized in women.
Living Wills Every competent adult has, in most cases, the freedom to accept or refuse... Women, Fertility and Cancer
Women who confront a cancer diagnosis before beginning or completing their families... Men, Fertility, and Cancer
Men who confront a cancer diagnosis before beginning or completing their families...
Liver Cancer Management
Jon Albert, founder of the Jack & Jill Late Stage Cancer Foundation shows the... Moving Bodies, Changing Lives
Moving On Aerobics helps women regain joy of movement and physical fitness after... Where Kids Can Be Kids… And Cancer Takes a Back Seat
Cancer camps for kids provide fun and camaraderie for children facing down a cancer...
Liver Cancer Clinical Trials
COGAEPI04C1 – Low Birth Weight & Other Risk Factors for Hepatoblastoma- A Groupwide Protocol
INSTOX-05-024 – Phase II Trial of Gemcitabine and Oxaliplatin (Gem-Ox) with Erlotinib (Tarceva) in the Treatment of Hepatocellular Carcinoma (HCC) in patients with adequate platelets (>100,000/?L)
ZX101-301 – A Phase II Randomized Controlled Study Comparing The Survival of Patients With Unresectable Hepatocellular Carcinoma (HCC) Treated With THYMITAQ To Patients Treated With Doxorubicin